An examination of retinal findings with optical coherence tomography in hypothyroidism patients with vitamin D deficiency: A comparative study

Samet Sayılan 1 * , Dila Kırağı 2, Mehmet Tayfun Arslan 3
More Detail
1 Department of Internal Medicine, Medicine Faculty, Kirklareli University, Kirklareli, Turkey
2 Department of Ophthalmology, Faculty of Medicine, Altinbas University, Istanbul, Turkey
3 Department of Ophthalmology Clinic, Kirklareli Educational and Research Hospital, Kirklareli, Turkey
* Corresponding Author
J CLIN MED KAZ, Volume 20, Issue 6, pp. 36-40.
OPEN ACCESS 687 Views 466 Downloads
Download Full Text (PDF)


Aim: This study aimed to examine the retinal layer before and after treatment in patients with hypothyroidism with vitamin D deficiency, since the vitamin also protects the retinal cells against inflammatory damage.
Material and methods: The free T3, free T4, and vitamin D levels of 104 patients with no ocular disease were first measured. Ophthalmological examinations of these patients, who were divided into three groups, were performed by specialist ophthalmologists, while retinal findings were examined using optical coherence tomography (OCT) and recorded. The first group was given vitamin D for three months, the second levothyroxine, and the third vitamin D + levothyroxine. After three months repeat OCT was performed, and the results were compared with the previous values.
Results: The thickness of the left inner nuclear cell layer of the patients in the vitamin D group increased significantly compared to pre-treatment. Post-treatment right central macular thickness, right nerve fiber layer, right outer nuclear cell layer, right pigment epithelial layer, left central macular, and left inner nuclear cell layer thicknesses were all significantly higher compared to pre-treatment in the patients in the levothyroxine + vitamin D group, while right outer retinal layer and left retinal nerve fiber thicknesses decreased (p<0.05).
Conclusion: A greater increase in cell layer thickness was observed in the group using vitamin D and levothyroxine together compared to those in which vitamin D and levothyroxine were employed alone. However, further studies on the effect of vitamin D on retinal cell development and protection against injury are now needed.


Sayılan S, Kırağı D, Arslan MT. An examination of retinal findings with optical coherence tomography in hypothyroidism patients with vitamin D deficiency: A comparative study. J CLIN MED KAZ. 2023;20(6):36-40.


  • Chistiakov DA. Immunogenetics of Hashimoto thyroiditis. J Autoimmune Dis. 2005;2:1.
  • Wiersinga WM. Clinical Relevance of Environmental Factors in the Pathogenesis of Autoimmune Thyroid Disease. Endocrinol Metab. 2016;31(2):213-223.
  • Bindra A, Braunstein GD. Thyroiditis. Am. Fam. Physician. 2006;73:1769-1776.
  • Pearce EN, Farwell AP, Braverman LE. Thyroiditis. New Engl J Med. 2003;348:2646-2655.
  • Ahn J, Park S, Zuniga B, Bera A, Song CS, Chatterjee B. Vitamin D in prostate cancer. Vitam Horm 2016;100:321-355.
  • Al Mheid I, Quyyumi AA. Vitamin D and cardiovascular disease: Controversy unresolved. J Am Coll Cardiol. 2017;4; 70(1):89-100.
  • Duque G, Daly RM, Sanders K, Kiel DP. Vitamin D, bones and muscle: Myth versus reality. Australas J Ageing. 2017;36 (Suppl 1):8-13.
  • Ekmekcioglu C, Haluza D, Kundi M. 25-hydroxyvitamin d status and risk for colorectal cancer and type 2 diabetes mellitus: A systematic review and meta-analysis of epidemiological studies. Int J Environ Res Public Health. 2017;14.
  • Field S, Davies J, Bishop DT, Newton-Bishop JA. Vitamin d and melanoma. Dermatoendocrinol. 2013;5:121-129.
  • Gaksch M, Jorde R, Grimnes G, Joakimsen R, Schirmer H, Wilsgaard T, et al. Vitamin D and mortality: Individual participant data meta-analysis of standardized 25-hydroxyvitamin D in 26916 individuals from a european consortium. PLoS One. 2017; 12:e0170791.
  • Grubler MR, Marz W, Pilz S, Grammer TB, Trummer C, Mullner C, et al. Vitamin-D concentrations, cardiovascular risk and events - a review of epidemiological evidence. Rev Endocr Metab Disord. 2017;18:259-272.
  • Hill TR, Aspray TJ. The role of vitamin d in maintaining bone health in older people. Ther Adv Musculoskelet Dis. 2017;9: 89-95.
  • Feart C, Helmer C, Merle B, Herrmann FR, Annweiler C, Dartigues JF et al. Associations of lower vitamin D concentrations with cognitive decline and long-term risk of dementia and Alzheimer's disease in older adults. Alzheimers Dement. 2017;13(11):1207-16.
  • Hribova P&Sotak S. Vitamin D and ophthalmopathias. A review. Cesk Slov Oftalmol. 2022;78(4):153-156.
  • Azimi A, Bonakdaran S, Heravian J, Layegh P, Yazdani N, Alborzi M. Pattern visual evoked potential in hypothyroid patients. Doc Ophthalmol. 2019;138(2):77-84.
  • Lee V, Rekhi E, Hoh Kam J, Jeffery G. Vitamin D rejuvenates aging eyes by reducing inflammation, clearing amyloid beta and improving visual function. Neurobiol Aging. 2012;33(10):2382-9.
  • Graffe A, Beauchet O, Fantino B, Milea D, Annweiler C. Vitamin D and macular thickness in the elderly: an optical coherence tomography study. Invest Ophthalmol Vis Sci. 2014;55(8):5298-303.
  • Ulas F, Uyar E, Tekce H, Celebi S. Can Hypothyroidism Cause Acute Central Serous Chorioretinopathy? Semin Ophthalmol. 2019;34(7-8):533540.
  • Ozturk BT, Kerimoglu H, Dikbas O, Pekel H, Gonen MS. Ocular changes in primary hypothyroidism. BMC Res Notes. 2009;2:66.
  • Yu L, Jiao Q, Cheng Y, Zhu Y, Lin Z, Shen X. Evaluation of retinal and choroidal variations in thyroid-associated ophthalmopathy using optical coherence tomography angiography. BMC Ophthalmol. 2020;20(1):421.
  • Fjeldstad C, Fjeldstad AS, Weir JP, Pardo G . Association of vitamin D deficiency with RNFL thickness in MS individuals without history of optic neuritis. Mult Scler Relat Disord. 2014;3(4):489-93.
  • Beauchet O, Milea D, Graffe A, Fantino B, Annweiler C. Association between serum 25-hydroxyvitamin D concentrations and vision: a cross-sectional population-based study of older adults. J Am Geriatr Soc. 2011;59:568-570.
  • Parekh N, Chappell RJ, Millen AE, Albert DM, Mares JA. Association between vitamin D and age-related macular degeneration in the Third National Health and Nutrition Examination Survey, 1988 through 1994. Arch Ophthalmol. 2007;125:661-669.
  • Millen AE, Voland R, Sondel SA. Vitamin D status and early age-related macular degeneration in postmenopausal women. Arch Ophthalmol. 2011;129: 481-489.
  • Morrison MA, Silveira AC, Huynh N. Systems biology-based analysis implicates a novel role for vitamin D metabolism in the pathogenesis of age-related macular degeneration. Hum Genomics. 2011;5: 538-568.
  • Graffe A, Milea D, Annweiler C. Association between hypovitaminosis D and late stages of age-related macular degeneration: a case-control study. J Am Geriatr Soc. 2012;60:1367-1369.
  • Ozturk E, Cankaya C. Effect of Vitamin D Deficiency on Contrast Sensitivity Function. Curr Eye Res. 2020;45(12):1619-1624.
  • Link YH, Mirabelli P, Lindehammar H, Link H. Retinal changes associated with multivitamin deficiency before and after supplementation. Acta Neurol Scand. 2021;144(2):209-215.
  • Aydemir E, Ilhan C, Aydemir GA, Bayat AH, Bolu S, Asik A. Evaluation of Retinal Structure in Pediatric Subjects With Vitamin D Deficiency. Am J Ophthalmol. 2022;233:30-37.
  • Robredo PF, Zamora JG, Recalde S, Malave VB, Bezunartea J, Hernandez M, et al. Vitamin D Protects against Oxidative Stress and Inflammation in Human Retinal Cells. Antioxidants (Basel). 2020;9(9):838.
  • Ekinci C, Guler EM, Kocyigit A, Kirik F, Ozdemir H. Effects of 1,25 Dihydroxyvitamin D 3 on Human Retinal Pigment Epithelial Cell Lines. Int Ophtalmo. 2021;41(10):3333-3340.